Similar articles

• Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality.

  Yildiz A, Soydinc S. Yildiz A, et al. Int J Cardiol. 2015 Apr 1;184:512-513. doi: 10.1016/j.ijcard.2015.03.029. Epub 2015 Mar 3. Int J Cardiol. 2015. PMID: 25756582 No abstract available.
• Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.

  Pastori D, Farcomeni A, Bucci T, Cangemi R, Ciacci P, Vicario T, Violi F, Pignatelli P. Pastori D, et al. Int J Cardiol. 2015 Feb 1;180:1-5. doi: 10.1016/j.ijcard.2014.11.112. Epub 2014 Nov 18. Int J Cardiol. 2015. PMID: 25460369
• Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).

  Washam JB, Stevens SR, Lokhnygina Y, Halperin JL, Breithardt G, Singer DE, Mahaffey KW, Hankey GJ, Berkowitz SD, Nessel CC, Fox KA, Califf RM, Piccini JP, Patel MR; ROCKET AF Steering Committee and Investigators. Washam JB, et al. Lancet. 2015 Jun 13;385(9985):2363-70. doi: 10.1016/S0140-6736(14)61836-5. Epub 2015 Mar 6. Lancet. 2015. PMID: 25749644
• Is there a role for digoxin in atrial fibrillation without heart failure?

  Master J, Schweitzer P. Master J, et al. Cardiol J. 2009;16(5):483-6. Cardiol J. 2009. PMID: 19753533 Review.
• Digoxin - time to take the gloves off?

  Eade E, Cooper R, Mitchell AR. Eade E, et al. Int J Cardiol. 2013 Apr 15;164(3):365-7. doi: 10.1016/j.ijcard.2011.07.034. Epub 2011 Jul 31. Int J Cardiol. 2013. PMID: 21807421 Review.